Ignite Creation Date:
2024-05-06 @ 12:06 AM
Last Modification Date:
2024-10-26 @ 10:45 AM
Study NCT ID:
NCT01495247
Status:
TERMINATED
Last Update Posted:
2020-12-08
First Post:
2011-09-30
Brief Title:
Phase IbII Trial of BEZ235 With Paclitaxel in Patients With HER2 Negative Locally Advanced or Metastatic Breast Cancer
Sponsor:
Novartis Pharmaceuticals
Organization:
Novartis
Key Dates - Follows AllAPIJSON File Order
Start Date:
2012-01-30
Start Date Type:
ACTUAL
Primary Completion Date:
2014-05-19
Primary Completion Date Type:
ACTUAL
Completion Date:
2014-05-19
Completion Date Type:
ACTUAL
First Submit Date:
2011-09-30
First Submit QC Date:
December 15 2011
Study First Post Date:
2011-12-19
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
2020-08-20
Disp First Submit QC Date:
August 20 2020
Disp First Post Date:
2020-08-27
Disp First Post Date Type:
ACTUAL
Last Update Submit Date:
2020-12-06
Last Update Post Date:
2020-12-08
Last Update Post Date Type:
ACTUAL